Impact of computerized dosing on eptifibatide-associated bleeding and mortality

Area of Science:

• Cardiology
• Pharmacology
• Medical Informatics

Background:

• Eptifibatide overdose increases bleeding risk and mortality.
• Renal function-based dosing is recommended but not widely implemented.
• Clinical impact of eptifibatide dosing algorithms needs assessment.

Purpose of the Study:

• Evaluate the impact of a computerized dosing algorithm on eptifibatide-associated bleeding.
• Assess the effectiveness of automated dosing in cardiac catheterization settings.
• Determine if algorithm implementation reduces bleeding complications and mortality.

Main Methods:

• Computerized algorithm using Cockroft-Gault formula for eptifibatide dosing (1 or 2 µg/kg/min based on creatinine clearance).
• Hemoglobin measured pre- and post-procedure.
• Comparison of 24-hour bleeding and in-hospital mortality before and after algorithm implementation.

Main Results:

• Increased appropriate eptifibatide dosing from 74.7% to 97.5% (P < .0001).
• Reduced 24-hour bleeding complications and hospital mortality (4.4% to 0%, P = .005).
• Similar packed red blood cell transfusion rates between groups (4.4% vs 2.1%, P = .26).

Conclusions:

• Computerized algorithm implementation led to appropriate eptifibatide dosing.
• Algorithm use was associated with reduced bleeding and mortality in cardiac catheterization patients.
• Automated dosing improves safety and outcomes for eptifibatide therapy.